Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase
Elena Di Gennaro(Istituto Giannina Gaslini), Alfredo Budillon(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Alessandra Di Cintio(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Claudio Arra(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Antonio Luciano(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Tania Moccia(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Geny Piro(University of Verona), Renato Franco(Istituto di Chimica Biomolecolare), Antonio Avallone(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Maria Chianese(University of Trieste), Francesca Bruzzese(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Immacolata Ruggiero(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cited by 49
Related Papers
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k
<i>BRAF/NRAS</i> Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
|Journal of Clinical Oncology|2012|460
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
|The Lancet. Gastroenterology & hepatology|2024|245
Emerging anti-cancer molecular mechanisms of aminobisphosphonates
|Endocrine Related Cancer|2006|131
Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation
|Journal of Experimental & Clinical Cancer Research|2019|125